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Abstract
Aims/hypothesis Beta cell death is a hallmark of diabetes. It is
not known whether specific cellular stresses associated with
type 1 or type 2 diabetes require specific factors to protect
pancreatic beta cells. No systematic comparison of endoge-
nous soluble factors in the context of multiple pro-apoptotic
conditions has been published.
Methods Primary mouse islet cells were cultured in condi-
tions mimicking five type 1 or type 2 diabetes-related stresses:
basal 5 mmol/l glucose, cytokine cocktail (25 ng/ml TNF-α,
10 ng/ml IL-1β, 10 ng/ml IFN-γ), 1 μmol/l thapsigargin,
1.5 mmol/l palmitate and 20 mmol/l glucose (all in the ab-
sence of serum). We surveyed the effects of a library of 206
endogenous factors (selected based on islet expression of their
receptors) on islet cell survival through multi-parameter, live-
cell imaging.
Results Our survey pointed to survival factors exhibiting gen-
eralised protective effects across conditions meant to model
different types of diabetes and stages of the diseases. For ex-
ample, our survey and follow-up experiments suggested that
OLFM1 is a novel protective factor for mouse and human beta
cells across multiple conditions. Most strikingly, we also
found specific protective survival factors for eachmodel stress
condition. For example, semaphorin4A (SEMA4A) was toxic
to islet cells in the serum-free baseline and serum-free
20 mmol/l glucose conditions, but protective in the context
of lipotoxicity. Rank product testing supported the consisten-
cy of our observations.
Conclusions/interpretation Collectively, our survey reveals
previously unidentified islet cell survival factors and suggest
their potential utility in individualised medicine.
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FGF Fibroblast growth factor
GLP1 Glucagon-like peptide-1
JAK Janus kinase
MAD Median absolute deviation
MIP-GFP Mouse insulin-1 promoter, green fluorescent
protein
OLFM1 Olfactomedin 1
PCA Principal component analysis
PI Propidium iodide
SEMA4A Semaphorin 4A
VIP Vasoactive intestinal peptide
Introduction
The loss of functional beta cell mass is critical in diabetes
pathogenesis [1]. Research aimed at discovering beta cell sur-
vival factors has typically been conducted one at a time and
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has been limited by prior knowledge [2–4]. Glucagon-like
peptide 1 (GLP1) is considered a gold standard for beta cell
protective factors [5]. Although local GLP1 increases islet
transplant success in animals [6], clinical evidence to support
its efficacy to durably increase human beta cell mass is lack-
ing. Clearly, there is an unmet need to identify more and better
beta cell survival factors.
Our efforts to identify novel factors with sustained anti-
apoptotic effects led us to mine expression databases and char-
acterise locally acting pro-survival factors in the islet
secretome, which includes >200 expressed ligands [7]. Our
initial analyses of candidates revealed glucose-dependent pro-
tective roles for Notch, Netrin and Slit [7–9]. However, with-
out a side-by-side comparison, it is impossible to determine
the relative merits of each candidate. We recently developed
high-throughput, kinetic, live-cell imaging methods that allow
the effects of hundreds of factors on multiple cell death pa-
rameters to be simultaneously evaluated in dispersed primary
islet cells over relatively long periods of time in culture [10].
Here, we surveyed 206 factors, rationally chosen based on
previous bioinformatic analysis [7], and ranked their effects
on islet cell survival under five distinct stress conditions. We
found many factors with previously unreported pro-survival
effects. Remarkably, each stress condition was associated with
a relatively distinct set of protective and deleterious factors,
consistent with fundamental mechanistic differences in the
cell death pathways. This first systems level analysis has im-
portant implications for the development of beta cell protec-
tive and regenerative therapies [11].
Methods
Multi-parameter imaging Mice were housed in accordance
with the University of British Columbia Animal Care Com-
mittee guidelines. After overnight culture, isolated islets were
dispersed and cultured for 48 h in 384-well plates. After
serum-free medium washes, cells were stained with Hoechst
33342, propidium iodide (PI), and annexinV-conjugated-
AlexaFluor647 prior to imaging with ImageXpressMICRO
(Molecular Devices, Sunnyvale, CA, USA) [9, 10, 12]. Cells
treated with the following conditions (all serum-free): 5 mmol/
l glucose; 20 mmol/l glucose; 25 ng/ml TNF-α, 10 ng/ml IL-
1β and 10 ng/ml IFN-γ cocktail; 1 μM thapsigargin;
1.5 mmol/l palmitate (complexed to BSA at 6:1 molar ratio)
[10, 13], were imaged every 3 h for 60 h in the presence of
10% vol./vol. FBS (positive control) or test factors (Electronic
Supplementary Material [ESM] Table 1) at 10 nmol/l final
concentration. Our imaging protocols have been described
[9, 10, 12] (see ESM Methods for further details).
Data analysis Images were analysed using MetaXpress soft-
ware (Molecular Devices) [9, 10, 12]. Cell loss, PI+ and
AnnexinV+PI- cells were calculated, as was AUC between
0–24 h and 24–48 h. For each individual experiment, z scores
were determined based on (x−median)/MAD, where MAD
represents the median absolute deviation. Rank product test-
ing was used to identify factors with consistent effects across
time and between replicate experiments and the results are
presented in principal component analysis (PCA) plots,
wherein the first component in the PCA plot illustrates the
agreement between the days, whereas the second component
highlights their differences. For western blot studies, analysis
of variance was calculated using GraphPad Prism (San Diego,
CA, USA), and results were considered statistically significant
when p<0.05, using the Tukey–Kramer post-hoc test (see
ESM Methods for further details). Data are expressed as
mean±SEM, unless otherwise stated.
Results
Factors with generalised effects on islet cell survival across
multiple conditions We set out to compare endogenous solu-
ble factors that may directly promote or inhibit survival under
five controlled stress conditions in dispersed mouse islet cells.
Mouse islet cells were chosen because of their reproducibility
and low baseline rates of apoptosis, relative to human islet
cells where the in vitro rates of cell death are typically much
higher and more variable. The cells were concurrently treated
with a library of 206 recombinant factors compiled using our
previous bioinformatics analysis of islet cell ligands and re-
ceptors [7], along with candidates from the literature (Fig. 1a).
Row and column variability in cell seeding density and cell
death was negligible (ESM Fig. 1a,b). Cells cultured in 0.1%
FBS and in the absence of serum displayed the same levels of
death (ESM Fig. 1c). Analysis of dispersed mouse insulin-1
promoter-green fluorescent protein (MIP-GFP) islet cells sug-
gested that beta cells were more sensitive to these stress con-
ditions compared with the non-beta cell population within the
same cultures (ESM Fig. 1c,d).
High-content, image-based analysis can simultaneously as-
sess multiple parameters for internal validation, providing a
level of redundancy that increases confidence in the results.
We measured the loss of Hoechst-positive cells and the accu-
mulation of PI-positive cells as indices of cell death. This
captures multiple forms of cell death, including the ‘partial
apoptosis’ that we recently demonstrated is the predominant
mode of death in cultured primary beta cells [10]. The results
of these studies revealed both pro-survival and pro-death fac-
tors within our library of endogenous ‘biologic’ factors,
consisting mostly of recombinant full-length proteins
(Figs 2, 3, 4, 5 and 6). Heatmaps showed the relative agree-
ment between the replicate experiments (Panel c in Figs 1, 2,
3, 4, 5 and 6, ESM Table 2). As expected, cells treated with
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our positive control (10% FBS, presumably containing high
concentrations of many islet survival factors) displayed the
lowest PI levels. The agreement between the measurements
of cell loss and PI incorporation can be seen in the distribution
of the top and bottom parts of Panel a in Figs 2, 3, 4, 5 and 6,
and is especially evident in stress conditions with larger effects
(i.e. cytokines, thapsigargin, palmitate). Divergence is expect-
ed if specific factors modified the adhesion of dead or dying
cells. The number of early apoptotic, AnnexinV-positive and
PI-negative cells was also analysed, but as we have recently
reported, these are relatively rare and their analysis is less
informative [10].
First, we compared effects of each factor across all of the
tested stresses to identify factors that might be generally pro-
tective or generally deleterious. We present the data here, and
elsewhere, in multiple ways. The heat map in Fig. 1b repre-
sents the simple average rankings of PI+ cell count and cell
loss, at two time blocks (0–24 h, 24–48 h), across all condi-
tions (see ESMMethods). This analysis is meant to be explor-
atory and does not provide statistical information on the extent
of protection or relative differences in protection among fac-
tors. Nevertheless, several known anti-apoptotic factors, in-
cluding insulin [4, 14, 15] and adiponectin [16–19], were
highlighted, as well as unexpected factors. Pan-protective fac-
tors included those that were ranked amongst the top ten most
potent survival factors under one or more conditions, along
with those displaying moderate but consistent effects across
all conditions. A sortable list of these results can be found in
ESM Table 2. We validated the survival effects of
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Fig. 1 Effects of 206 factors on islet cell survival across five conditions.
(a) Study design. (b) PI-positive (PI+) cell percentage was determined
following treatments with 206 factors [10 nmol/l] in one of five condi-
tions. Data presented as z scores for the 0–24 and 24–48 h time intervals
for each replicate. Factors were ranked for overall protective effect (low
levels of cell loss [CL] and low levels of PI+ cells [PI] equates to high
protection). SF, serum-free; C, cytokines; T, thapsigargin; P, palmitate.
The top ten factors are listed to the side. (c) Rank product analysis of PI+
cell data (see ESMMethods for details). The first component in the PCA
plot illustrates the agreement between the days, whereas the second com-
ponent highlights their differences. Nominally significant factors for any
one day are highlighted with three arrows (representing 3 days: top arrow,
day 1; middle arrow, day 2; and bottom arrow, day 3). Coloured arrows
are significant for that day. See ESM Table 1 for protein abbreviations




















































































































Fig. 2 Effects of 206 factors in a baseline serum-starved condition. Islet
cells were treated with 206 factors in 5 mmol/l glucose serum-free con-
ditions. (a) Cell loss and PI-positive cell percentage (PI+). 10% FBSwas a
positive control. z scores for 0–24 and 24–48 h time intervals after order-
ing based on the level of cell loss in 0–24 h (n=3,mean±SEM). Solid line
represents median. (b) Insulin in the culture media collected after 72 h
(n=3, mean±SEM). (c) Factors ranked based on low cell loss (CL) and
low PI+ (PI) cell number (green-red heat maps). AnnexinV+PI- cells (A)
are shown with blue-yellow and insulin (I) with orange-purple. The top
ten protective factors under each condition are listed. See ESM Fig. 8 for





















































































































Fig. 3 Effects of 206 factors in
the context of toxic cytokines.
Cells treated with 206 factors and
cytotoxic cytokines in 5 mmol/l
glucose serum-free conditions.
(a–c) Data presented as in Fig. 2
(n=2, mean). See ESM Fig. 9 for
PCA plot of rank product testing
analysis; see ESM Table 1 for
protein abbreviations; DYNA,
dynorphin A
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other factors on MIP-GFP beta cells (ESM Fig. 2-5). We con-
firmed that OLFM1 dose-dependently promotes human islet
cell survival under lipotoxic conditions (ESM Fig. 6). Mech-
anistically, OLFM1 significantly downregulated p38 MAPK
and caspase-3-dependent apoptotic signalling (p<0.05; ESM
Fig. 7).
We measured the consistency between replicates using










































































































aFig. 4 Effects of 206 factors in
the context of ER stress. Cells
treated with 206 factors and
thapsigargin in 5 mmol/l glucose
serum-free conditions. (a–c) Data
presented as in Fig. 2 (n=2,
mean). See ESM Fig. 10 for PCA
plot of rank product testing

















































































































aFig. 5 Effects of 206 factors in
the context of lipotoxicity. Cells
treated with 206 factors and
palmitate in 5 mmol/l glucose
serum-free conditions. (a–c) Data
presented as in Fig. 2 (n=2,
mean). See ESM Fig. 11 for PCA
plot of rank product testing
analysis; see ESM Table 1 for
protein abbreviations
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was log2 scaled and then divided by theMAD of scores for the
plate. Results for each well were then aggregated for day 1,
day 2 and day 3 as the median cell death score for the day,
providing a measure of the durability of protection. Statistical
significance was measured as the reproducibility of cell death
score ranks across replicate plates. As the factors were pre-
selected, with expected and non-independent effects, we rea-
soned that naive multiple testing correction would be too con-
servative. Factors that were nominally significant (i.e.
p<0.05) on any day are illustrated with a triple triangle, with
the significant days illustrated by filled triangles in PCA plots
(Fig. 1c, ESM Fig. 8-12). The protective effect of 10% serum,
our positive control, was globally statistically significant
(p<0.05) over all 3 days of testing, but is not shown in PCA
plots so that the test factors can be more easily viewed. The
complete analysis, with p values for each factor can be found
in ESM Table 3. Semaphorin 4A (SEMA4A) held up against
the most conservative of multiple testing correction, and 41
nominally statistically significant factors were identified as
being pro- or anti-survival over all 3 days tested. Each will
require further testing to rule out multiple testing false posi-
tives. Using this approach of nominal statistical significance,
adrenocorticotropic hormone (ACTH) and neurotrophin 4
were consistently significantly protective over all 3 days
(p<0.05), whereas OLFM1, somatostatin, chemokine (C-X-
C motif) ligand 11 (CXCL11), fibroblast growth factor
(FGF)1, IGF1, bone morphogenic protein 15, ephrin 4A,
xenin 8 and FGF12 showed significant time-dependency of
protection. The results differ from the raw average of rankings
for several reasons, including the omission of cell count data
(which was informative in the qualitative analysis, but diffi-
cult to combine into the ‘cell death score’), the adoption of raw
data normalisation and the inclusion of the 3rd time block
(49–60 h). Collectively, results of both qualitative and statis-
tical analyses suggest that factors exist that may protect islet
cells under a wide range of stress conditions.
Stress-specific factors affecting islet cell survival Comparing
the effects of our chosen factors among stresses revealed that
each stress had a relatively distinct complement of pro-
survival factors and that there was little overlap between the
highly ranked and nominally significant pro-survival or anti-
survival factors found for each of the five stress conditions
(Figs 1, 2, 3, 4, 5 and 6). For example, oncostatin M, from
the cytokine family that includes leukaemia inhibitory factor,
granulocyte-colony stimulating factor and IL-6 [20], was pro-
tective in context of both thapsigargin and high glucose, but
no such evidence could be found in the context of low glucose
serum withdrawal and the toxic cytokine cocktail (Fig. 6,
ESM Table 2). Members of the neuroligin family, including
NLGN1 and NLGN4, showed bias towards protection in en-
doplasmic reticulum (ER) stress and lipotoxicity, which we
and others have shown are mechanistically linked [13, 21],
and these findings were confirmed with secondary validation
(ESM Fig. 4 and 5).
Comparing different stress conditions also revealed factors
that were pro-survival under one condition, but pro-death un-

























































































































aFig. 6 Effects of 206 factors in
the context of hyperglycaemia.
Cells treated with 206 factors in
20 mmol/l glucose serum-free
conditions. (a–c) Data presented
as in Fig. 2 (n=2, mean). See
ESM Fig. 12 for PCA plot of rank
product testing analysis; see ESM
Table 1 for protein abbreviations
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roles in axon guidance, morphogenesis, carcinogenesis and
immunomodulation [22], was the 2nd highest ranked (and
most statistically consistently highly ranked) protective factor
in the context of palmitate lipotoxicity, but it promoted cell
death under all other conditions tested, including the baseline
serum-free condition and the high glucose serum-free condi-
tion where it was the most consistently toxic factor (p<0.05;
Figs 1, 2, 3, 4, 5 and 6).
Some of our stress conditions were more resistant to pro-
tection than others (Figs 1, 2, 3, 4, 5 and 6). For example, only
37 factors provided any numerical protection of islet cells
from palmitate above the negative PBS control, with the rest
of the factors being apparently neutral or exacerbating
lipotoxic cell death (Fig. 5). On the other hand, more
than half of the factors provided some protection in the
context of ER stress induced by a moderate dose of
thapsigargin (Fig. 4). The shallow shape of the curve
in Fig. 2a suggests that serum withdrawal alone was
not a very severe stress in our studies, most likely be-
cause the islet cells can supply themselves with
autocrine/paracrine survival factors.
Concentration and time dependence of beta cell survival
factors We compared the concentration-dependent effects of
each factor on cell survival under 5 mmol/l serum-free condi-
tions (ESM Fig. 13). Some factors showed classical
concentration-dependent effects. However, other factors ex-
hibited bell-shaped dose–response curves, a phenomenon we
have consistently observed with insulin [4, 14]. Temporal
analysis revealed that some factors showed protective effects
throughout the entire time course, while others were only pro-
tective early. It remains to be determined whether these tran-
siently effective factors were rapidly degraded or taken up
following treatment or whether the cells displayed receptor
desensitisation.
When survival effects were analysed by pooling rank data
from both the 0.1 nmol/l and 10 nmol/l concentrations, some
factors that were not originally identified as protective when
given in moderate concentrations, were shown to have effica-
cy at the lower concentrations (ESM Fig. 14). For example,
cryptic family 1, γ-melanocyte stimulating hormone, somato-
statin and ephrin-B2 were ranked with higher protective ef-
fects when the low and moderate concentrations were taken
into consideration. Rank product testing of the entire
0.1 nmol/l data set (i.e. all factors across all tested conditions)
identified hepatocyte growth factor, vascular endothelial
growth factor-C, sonic hedgehog and serum amyloid-A1 as
factors with statistically significant consistent protection
across all 3 days at this dose (p<0.05; ESM Fig. 15). Identi-
fying factors with pro-survival effects under lower concentra-
tions is widely considered to be important for therapeutic de-
velopment because low effective concentrations may help re-
duce off-target effects.
Classification of survival factors by signal transduction
pathways Qualitative analysis of the canonical signalling
pathways stimulated by the protective factors revealed that
pro-survival signalling could be mediated by a number of
known pathways, including the janus kinase (JAK)–signal
transducer and activator of transcription (STAT) cytokine re-
ceptors, G-protein-coupled receptors, tyrosine kinase recep-
tors, serine/threonine kinase receptors and axon guidance re-
ceptors (Fig. 7a, b). These analyses revealed that specific sig-
nalling pathways were more important in the context of cer-
tain stresses, relative to others. In the baseline serum with-
drawal condition, factors that stimulate phospholipase C
and/or the activation of adenylyl cyclase tended to be protec-
tive, whereas factors that inhibit adenylyl cyclase were less
effective. In the context of thapsigargin or palmitate, activa-
tion of adenylyl cyclase was identified as the predominant
pro-survival G-protein-mediated pathway.
Context-dependent effects on chronic insulin release We also
assessed insulin accumulation in the media. We identified fac-
tors that promoted both survival and insulin accumulation in
the media, including angiopoietin 2 in the 5 mmol/l glucose
serum-free condition (Fig. 2b). Our crude data do not allow us
to distinguish whether the survival effects were due to insulin
independent survival signalling or pro-survival autocrine in-
sulin signalling [4, 15]. Other factors were protective while
inhibiting insulin accumulation in the media. It is known that
inhibition of calcium flux can protect beta cells under specific
conditions [23, 24], while these same manipulations block
insulin secretion [25]. We also detected factors, such as
semaphorin 4A, which triggered cell death and increased in-
sulin in media, likely secondary to the loss of cell integrity
(Figs 2b and 3b). The effects of soluble factors on insulin
release were context-dependent. Analysis of insulin release
was not a primary endpoint in the present study, although
these data nonetheless provide a starting point for additional
detailed studies.
Discussion
The goal of the present study was to simultaneously compare
the effects of 206 putative beta cell survival factors, under
multiple conditions, using a newly developed imaging plat-
form. Our survey pointed to many previously unappreciated
factors that may protect islet cells. A principal observation was
that each cellular stressor examined appears to require its own
unique set of protective factors, and that factors (i.e.
SEMA4A) can switch from pro-death to pro-survival. These
findings have significant implications for the understanding of
the molecular mechanisms controlling beta cell fate and for
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the development of therapeutic approaches to prevent or treat
type 1 or type 2 diabetes at various disease stages.
Factors were selected for testing based on their expression
or the expression of their receptors in islets. Harnessing local
islet autocrine and/or paracrine survival factor signalling may
be an ideal scenario for diabetes prevention or treatment.
Many local factors act on self-limiting signalling mechanisms
that prevent over-stimulation. Insulin, for example, is a potent
and self-limiting islet survival factor and physiological doses
of insulin can increase beta cell proliferation [15, 26, 27]. An
unbiased search for other potent survival factors not involved
in peripheral metabolism is needed. Another approach would
be to exploit pancreatic development factors, including Notch,
TGF-beta superfamily, FGFs and bone morphogenic proteins
[8, 28–31]. We also cannot overlook the potential importance
of distally secreted factors, including adipokines such as
adiponectin.
In type 1 diabetes, beta cells may be destroyed by a com-
bination of toxic cytokines and other factors including gran-
zyme, perforin and Fas [32, 33]. Studies have also implicated
ER stress in beta cell death associated with type 1 diabetes
[34]. Thus, it is possible that factors showing protection in
both of these conditions may be therapeutic in type 1 diabetes.
In type 2 diabetes, excessive fatty acids and ER stress act
through partially common pathways to increase beta cell death
following the initial compensation phase [13, 35, 36]. These
stresses had in common protection by OLFM1, neuroligin
family members and members of the FGF family. Notably,
the known beta cell anti-apoptotic factors, insulin and IGF2
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Fig. 7 Manual annotation of
signal transduction pathways of
islet cell survival factors. (a)
Canonical signalling pathways
regulated by top factors. (b) The
proportion of factors displaying
protective effects with z scores
values below 2× MAD of each
condition (for cell loss or PI+
measurements in the 0–24 or 24–
48 h intervals) categorised by
signalling pathway. (c) Proportion
of factors signalling through
specific G-protein-coupled
receptor (GPCR) pathways; rel.,
relative; see ESM Table 5 for
protein abbreviations
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consistently relative to the other stresses. Persistent
hyperglycaemia, present in poorly controlled type 1 or type
2 diabetes, induces further beta cell apoptosis [38–40] and
factors that are protective under this condition may be candi-
dates for adjunct or second-line treatments.
Some factors promoted survival under only one condition.
The most striking of these was the palmitate specific pro-
survival effect of semaphorin 4A, which acts through plexin
receptors expressed in beta cells [41]. Clearly, this factor
would not be an ideal therapeutic target owing the presence
of multiple, concurrent beta cells stresses in vivo. While it
might seem counter-intuitive to some that islets would re-
spond to an endogenous factor with significant death, it is
possible that the local concentrations of semaphorin 4A are
lower than the toxic levels employed in our experiments and
that this factor plays an important role in constraining exces-
sive beta cell growth. We expect that functional beta cell mass
is controlled in vivo by a robust balance of positive and neg-
ative factors [31].
In addition to the discovery of stress-specific islet
cell survival factors, our analyses also enabled the iden-
tification of factors with generalisable survival effects
across different conditions. Using the simple average
ranking analysis of both PI and cell loss data over the
first two days, the most broadly effective protective fac-
tors appeared to be melanin-concentrating hormone, va-
soactive intestinal peptide (VIP) and adiponectin.
Melanin-concentrating hormone plays a role in obesity
and has been implicated in islet growth [42]. VIP has
known effects on insulin secretion [43]. Adiponectin is
an insulin sensitising adipokine that protects beta cells
against multiple stresses as found in our research and
that of others [16–19]. Anti-apoptotic effects of
adiponectin may not extend to all cell types [44], sug-
gesting a degree of beta cell specificity. Using the rank
product testing to assess the consistency of PI incorpo-
ration observations over 3 days, we identified several
‘pan-protective’ factors including neurotrophin 4,
ACTH, FGF 12, somatostatin and OLFM1. We believe
both the simple average ranking and the rank product
testing have value, as they represent different aspects of
the data and may be differentially influenced by multi-
ple factors, including peptide stability in storage over
the ~3 years these studies took place.
Our findings complement previous studies on the pro-
survival signalling mediated by axon guidance factors, netrins
and slits [7, 9]. We observed effects of slits, neuroligins and
semaphorins in our parallel comparisons, all factors known to
modulate the actin cytoskeleton and play roles in pancreas
morphogenesis [30]. In the present study, we chose to pursue
OLFM1, also known as noelin 1 or pancortin. OLFM1 is a
modulator of Wnt signalling involved in neuronal develop-
ment and axon elongation [45], which interacts with the Nogo
A receptor (NgR1) complex [46] expressed in beta cells [41].
Our studies demonstrated a dose-dependent effect of OLFM1
on mouse and human beta cell survival in a number of condi-
tions. Thus, despite a lack of adequate statistical power within
each condition, our survey/ranking approach identified a nov-
el beta cell survival factor, with conserved effects in mouse
and human cells. Although confirming the effects of other
interesting factors in human islets is beyond the scope of this
project, it is essential to take most of these observations be-
yond the exploratory stage. We expect our survey will be
broadly applicable to human islets, because the factors we
surveyed were selected based on both rodent and human ex-
pression studies [7] and because our previous studies suggest
broadly similar cell survival pathways in mouse and human
islets [7, 8, 13, 47]. Recent RNA sequencing analysis con-
firms remarkable similarity between species, with only
~1.5% of genes being unique to either mouse or human beta
cells [41, 48]. However, approximately 6% of genes
show species enrichment, including 61 ligands or recep-
tors (ESM Table 4), including the enrichment of Prlr,
Ghr and Cntfr in mouse beta cells compared with hu-
man beta cells [41, 48]. Interestingly, SEMA4A is also
enriched in mouse beta cells [41, 48]. One caveat is that
the mice used to generate these transcriptomic data sets
were 3–6 months old (a time when mice are still grow-
ing), whereas the humans donors averaged ~55 years of
age, meaning that some of the gene expression differ-
ences can be ascribed to relative age differences.
Collectively, our survey of endogenous soluble fac-
tors identified multiple hormones/cytokines/growth fac-
tors with robust islet cell survival effects under five
stress conditions designed to model aspects of type 1
and type 2 diabetes. Perhaps the most important finding
was that beta cells were best protected from each spe-
cific stress condition by a relatively distinct set of fac-
tors. This observation provides important insight into
the complexity of beta cell survival signalling pathways
and guides therapeutic efforts to protect beta cells.
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